Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.
Saved in:
| Title: | Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study. |
|---|---|
| Authors: | Rubbert-Roth, Andrea1 (AUTHOR) andrea.rubbert-roth@kssg.ch, Kato, Koji2 (AUTHOR), Haraoui, Boulos3 (AUTHOR), Rischmueller, Maureen4,5 (AUTHOR), Liu, Yanxi2 (AUTHOR), Khan, Nasser2 (AUTHOR), Camp, Heidi S.2 (AUTHOR), Xavier, Ricardo M.6 (AUTHOR) |
| Source: | Rheumatology & Therapy. Oct2024, Vol. 11 Issue 5, p1197-1215. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21986576 |
|---|---|
| DOI: | 10.1007/s40744-024-00694-x |
